Author : Mirko Manchia
Publisher : Frontiers Media SA
Page : 177 pages
File Size : 15,89 MB
Release : 2020-08-27
Category :
ISBN : 2889639622
Author : Robin M. Murray
Publisher : Cambridge University Press
Page : 0 pages
File Size : 12,61 MB
Release : 2009-10-01
Category : Medical
ISBN : 9780521121026
An international team of leading researchers and clinicians provides the first comprehensive, epidemiological overview of this multi-faceted and still-perplexing disorder. Controversial issues such as the validity of discrete or dimensional classifications of schizophrenia and the continuum between psychosis and 'normality' are explored in depth. Separate chapters are devoted to topics of particular relevance to schizophrenia such as suicide, violence and substance abuse. Finally, new prospects for treatment and prevention are considered.
Author : Mark A. Geyer
Publisher : Springer Science & Business Media
Page : 456 pages
File Size : 22,33 MB
Release : 2012-10-01
Category : Medical
ISBN : 3642257585
This volume tries to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters also deal with respective experimental and clinical methodology, biomarkers, and translational aspects of drug development. The volume concentrates on reviewing the ongoing research attempting to identify novel treatments for the cognitive deficits and negative symptoms of schizophrenia, which are not treated adequately by current antipsychotic medications.
Author : Bernhard Baune
Publisher : Academic Press
Page : 604 pages
File Size : 15,60 MB
Release : 2019-10-16
Category : Medical
ISBN : 0128131772
Personalized Psychiatry presents the first book to explore this novel field of biological psychiatry that covers both basic science research and its translational applications. The book conceptualizes personalized psychiatry and provides state-of-the-art knowledge on biological and neuroscience methodologies, all while integrating clinical phenomenology relevant to personalized psychiatry and discussing important principles and potential models. It is essential reading for advanced students and neuroscience and psychiatry researchers who are investigating the prevention and treatment of mental disorders. Combines neurobiology with basic science methodologies in genomics, epigenomics and transcriptomics Demonstrates how the statistical modeling of interacting biological and clinical information could transform the future of psychiatry Addresses fundamental questions and requirements for personalized psychiatry from a basic research and translational perspective
Author : Katherine J. Aitchison
Publisher : CRC Press
Page : 152 pages
File Size : 42,13 MB
Release : 1999-02-17
Category : Medical
ISBN : 9781853174353
The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management.
Author : Linda P. Barnes
Publisher : Nova Publishers
Page : 636 pages
File Size : 47,23 MB
Release : 2007
Category : Medical
ISBN : 9781600210563
The terms pharmacogenomics and pharmacogenetics tend to be used interchangeably, and a precise, consensus definition of either remains elusive. Pharmacogenetics is generally regarded as the study of genetic variation that gives rise to differing response to drugs, while pharmacogenomics is the broader application of genomic technologies to new drug discovery and further characterization of older drugs. Pharmacogenetics considers one or at most a few genes of interest, while pharmacogenomics considers the entire genome. Much of current clinical interest is at the level of pharmacogenetics, involving variation in genes involved in drug metabolism with a particular emphasis on improving drug safety. This new book presents leading-edge research in this dynamic field.
Author : Peter F. Buckley
Publisher : Springer Science & Business Media
Page : 231 pages
File Size : 45,1 MB
Release : 2014-03-18
Category : Medical
ISBN : 3642452574
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.
Author : H.G. Baumgarten
Publisher : Springer
Page : 810 pages
File Size : 31,79 MB
Release : 1997-08-14
Category : Medical
ISBN :
With contributions by numerous experts
Author : Gustavo H. Vazquez
Publisher : Academic Press
Page : 170 pages
File Size : 33,31 MB
Release : 2020-09-16
Category : Medical
ISBN : 0128210346
Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. Provides efficacy research on ketamine as a treatment for depression Identifies best practices for clinical use, both long-term and acute Discusses the molecular mechanisms and neurobiology of action
Author : Judith Pratt
Publisher : Springer
Page : 437 pages
File Size : 22,93 MB
Release : 2019-01-05
Category : Medical
ISBN : 3319996428
This volume addresses one of the Holy Grails in Psychiatry, namely the evidence for and potential to adopt ‘Biomarkers’ for prevention, diagnosis, and treatment responses in mental health conditions. It meshes together state of the art research from international renowned pre-clinical and clinical scientists to illustrate how the fields of anxiety disorders, depression, psychotic disorders, and autism spectrum disorder have advanced in recent years.
